With the new Protocol Creator software, clinical teams will be able to create and review protocol documentation in a purpose-built collaborative environment.

The software simplifies the production of protocol documents and saves time while ensuring quality through the adherence to industry standards.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Cognizant senior vice-president and Life Sciences global head Bhaskar Sambasivan said: “Cognizant Protocol Creator redesigns the entire submission process to be digital first as opposed to one built around antiquated systems that were never intended for writing clinical protocols.

“Not only does it shorten the time to create the protocol and improve its quality, it lays a foundation for a fully digital lab and clinical eco-system that uses automation and artificial intelligence to improve clinical outcomes.”

Protocol Creator aims to obtain a protocol to submission faster and generates clinical trial documentation as a structured document.

Furthermore, using the software, teams can collaborate, manage review cycles and deadlines. It also enables publishing of the final protocol as a traditional document or in machine-readable formats.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Cognizant Accelerator, the company’s product and platform incubator and venture investing division, conceived, validated and developed Cognizant Protocol Creator.

Cognizant Accelerator collaborated with Cognizant Life Sciences to introduce the software to the market.

Cognizant Accelerator vice-president and general manager Todd Paoletti said: “We are firmly focused on delivering transformational products that adopt digital technologies to drive efficiencies throughout an organisation.

“Cognizant Protocol Creator demonstrates this focus, as it plugs a gap in the clinical trial lifecycle that has been, to date, ignored by most technology vendors.”

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact